Association between Ag-NOR dots and immunohistochemical markers in different grades of breast ductal carcinoma

Authors

  • Tagwa Mohamed Ahmed Fadil Department of medical Laboratory Sciences, Napata College-Bahri city, Sudan
  • Mona Mohammed Hashim Ellaithi Faculty of medical Laboratory Sciences- Al Neelain University-Khartoum city, Sudan
  • Alkhair Abd Almahmoud Idris Ahfad University for Women, Omdurman city, Sudan https://orcid.org/0000-0002-9278-5591

DOI:

https://doi.org/10.15419/bmrat.v11i5.889

Keywords:

AgNOR, ER, Progesterone receptors, immunohistochemical expression, H and E

Abstract

Background: Breast cancer is recognized as a significant health issue in developed countries.

Methods: This study aimed to correlate the presence of Ag-NOR (argentophilic nucleolar organizer region) dots with immunohistochemical markers across various grades of breast ductal carcinoma. A total of 100 samples were divided into a test group and a control group, with the former comprising blocks of breast adenocarcinoma and the latter involving blocks of breast fibroadenoma. Each sample was sectioned twice; the first section was stained with Hematoxylin and Eosin (H&E), and the second utilized the Ag-NOR staining technique. The mean Ag-NOR (mAg-NOR) count and the proliferative Ag-NOR (pAg-NOR) count were calculated. Subsequent to microscopic examination of the sections, the laboratory findings and patient demographic data were analyzed.

Results: The majority of ductal carcinoma cases were classified as grade 2. The number of Ag-NOR dots was significantly greater in ductal carcinoma cases than in benign lesions. Furthermore, an increase in the number of Ag-NOR dots was observed with advancing tumor grade.

Conclusions: A strong correlation was identified between the count of Ag-NOR dots and the expression of immunohistochemical markers within different grades of breast ductal carcinoma.

Downloads

Published

2024-05-31

Issue

Section

Report

How to Cite

Association between Ag-NOR dots and immunohistochemical markers in different grades of breast ductal carcinoma. (2024). Biomedical Research and Therapy, 11(5), 6434-6441. https://doi.org/10.15419/bmrat.v11i5.889

Similar Articles

51-60 of 671

You may also start an advanced similarity search for this article.